Page 2 - Yoon Sik Lee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail IMAGE: A schematic diagram of the application of cancer-targeted supermolecular peptide phototherapy drugs to animal experiments developed by KIST researchers. A single supermolecular peptide phototherapy injection and repeated phototherapy were used. view more  Credit: Korea Institute of Science and Technology(KIST) Researchers in South Korea have developed a phototherapy technology that can significantly increase efficiency while reducing the pain of chemotherapy and minimizing side effects after treatment. The President of Korea Institute of Science and Technology (KIST), Seok-Jin Yoon announced that a research team led by Dr. Sehoon Kim at the Theragnosis Research Center (KU-KIST Graduate School of Converging Science and Technology) has developed a cancer-targeted phototherapeutic agent that promises complete elimination of cancer cells without side effects. It involves only one injection and repeated phototherapy. This development was made through joint res

Soult ukpyolsiSouth koreaYoon sik leeDong june ahnSeokjin yoonInstitutional rd programKorea universityTheragnosis research centerSeoul national universityKorea institute of scienceSchool of converging scienceMinistry of scienceKorea instituteSe hoon kimConverging scienceProfessor dong june ahn